|Articles|January 1, 2016
- Pharmaceutical Executive-01-01-2016
- Volume 36
- Issue 1
Pharmaceutical Executive, January 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive January 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 10 years ago
Feeling the Heat: Pharm Exec's 2016 Industry Forecastover 10 years ago
Ferring: The Quiet Companyover 10 years ago
Feel the Earth Move Under Your Brand?over 10 years ago
Is the Hatch-Waxman System Broken?over 10 years ago
2015 FDA Drug Approvalsover 10 years ago
Rough Road Ahead for Innovationover 10 years ago
Country Report: Puerto RicoNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Asembia ASX26: Adjusting Strategies to Adapt to an Uncertain Global Political and Regulatory Market
2
Which Supply Chains are Most Exposed by Disruptions in The Strait of Hormuz?
3
Teva Enters $900 Million Agreement to Acquire Emalex
4
Pharmaceutical Risks in the Strait of Hormuz
5